Merck KGaA reports Q1 results
Source: SeekingAlpha
2026-05-13 06:46:46 ET
More on Merck KGaA
- Merck KGaA: Small Breakout In 2026, Followed By Normalization
- Merck KGaA (MKKGY) Presents at BNP Paribas Exane Healthcare Conference - Slideshow
- Merck KGaA: Diversified Innovation At An Attractive Valuation
- Inhibrx cancer drug reportedly drawing interest of Merck and rivals
- Merck KGaA falls on lackluster guidance for 2026
Read the full article on Seeking Alpha
For further details see:
Merck KGaA reports Q1 results
Merck KGAA
NASDAQ: MKGAF
MKGAF Trading
0.76% G/L:
$165.39 Last:
143 Volume:
$164.436 Open:
MKGAF Latest News
July 22, 2025 09:00:00 pm
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
